None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Healthy adult population with no chronic illness, and no reported acute illness for the last 3 months, normal blood biochemistry normal clinical history, good general health
Exclusion criteria
Exclusion criteria: allergies, intolerances, hypersensitivity, severe anemia (Hb <8g/dl), medication use, history of infectious diseases, physical or psychiatric, or surgical intervention.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Colonic handling of undigested proteinTimepoint: Two time crossover measurement with bio specimen collection over 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of protein digestion & absorption by metabolomic & peptidomic approach.Timepoint: Enteric coated protein study: 6 h post dose, blood samples will be collected over 24 h, along with breath, urine & fecal sample to measure the appearance of labelled biomolecules & bacterial metagenome profiling. Non-enteric coated protein study: Hourly blood samples will be collected post dose for 6 h. For allo-isoleucine colonoscopy protocol, one time measurement with biospecimen collection over 4 h after the dose administration for colonic absorption. | — |
Countries
India
Contacts
St. Johns Research Institute